Oviva provides reimbursed digital care for obesity and chronic weight-related conditions, notably in Germany, the United Kingdom and Switzerland. The USD 220 million Series D, combining primary and secondary capital, will fund new markets, new conditions and its AI platform.
- Announced on
- Round
- Series C and later
- Amount
- USD 220 M
- Location
- canton of Schwyz
- Sector
- Health & medtech
Investors
- Kinnevik lead
- Temasek
- Sofina
- Planet First Partners
- A.P. Moller Holding
- Lunate
- EGS Beteiligungen AG
- Norrsken VC
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic